Jump to content
  • The effectiveness of vaccination against Long Covid: A rapid evidence briefing (February 2022)

    • UK
    • Data, research and analysis
    • Pre-existing
    • Creative Commons
    • No
    • UK Health and Security Agency
    • Everyone

    Summary

    The UK Health Security Agency (UKHSA) has undertaken a rapid evidence review looking at the effects of vaccination against Long COVID or post-COVID symptoms. The review includes 15 UK and international studies that were undertaken up until January 2022.

    An estimated 2% of the UK population have reported symptoms of long COVID or post-COVID syndrome, which can last for more than 4 weeks after their initial infection. The three most common symptoms are fatigue, shortness of breath and muscle or joint pain.

    Eight of the studies in the review looked at the effect of vaccinations administered before infection. Most of these studies suggest that vaccinated people (1 or 2 doses) were less likely to develop symptoms of long COVID following infection compared with unvaccinated people – in the short term and long term (4 weeks up until 6 months after infection).

    Content

    The data from some of the studies included in the review suggests that:

    • people with COVID-19 who received 2 doses of the Pfizer, AstraZeneca, or Moderna vaccines or one dose of the Janssen vaccine, were about half as likely as people who received one dose or were unvaccinated to develop long COVID symptoms lasting more than 28 days.
    • vaccine effectiveness against most post-COVID symptoms in adults was highest in people aged 60 years and over, and lowest for younger participants (19 to 35 years).

    The remaining studies looked at the effects of vaccination among people who already had long COVID symptoms.

    Four studies specifically compared long COVID symptoms before and after vaccination. Three of these studies suggested that more people with COVID-19 reported an improvement than a worsening in symptoms after vaccination, either immediately or over several weeks.

    Another 3 studies of unvaccinated people with long COVID compared ongoing symptoms in those who either went on to receive a vaccination or remained unvaccinated. These studies suggested that those who were vaccinated were less likely to report long COVID symptoms after vaccination than people who remained unvaccinated over the same period.

    One study looked specifically at the timing of vaccination after COVID-19 infection and suggested that people with COVID-19 who were vaccinated sooner after diagnosis were much less likely to report long COVID symptoms than people who were vaccinated later after diagnosis. All studies were observational, so results may be from differences other than vaccination.

    In one study, of those participants who reported having long COVID, a greater proportion of vaccinated participants said their symptoms improved compared to unvaccinated participants (23.2% compared to 15.4% respectively).

    The effectiveness of vaccination against Long Covid: A rapid evidence briefing (February 2022) https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff
    0 reactions so far

    0 Comments

    Recommended Comments

    There are no comments to display.

    Create an account or sign in to comment

    You need to be a member in order to leave a comment

    Create an account

    Sign up for a new account in our community. It's easy!

    Register a new account

    Sign in

    Already have an account? Sign in here.

    Sign In Now
×